• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 14, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Cancer cells will become vulnerable

Bioengineer by Bioengineer
July 8, 2019
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

DNA secondary structures lead to gene mutations that increase the risk of cancer

The Researchers from HSE University (The Higher School of Economics) have used machine learning to discover that the two most widespread DNA structures – stem-loops and quadruplexes – cause genome mutations that lead to cancer. The results of the study were published in BMC Cancer.

In the early 2000s, researchers invented a new method to obtain the nucleotide sequence of DNA and RNA – Next-Generation Sequencing, NGS. This technology allows reading simultaneously several million genome regions, which had been impossible with earlier sequencing methods. Now, the human genome (genetic information) can be recorded in a text file weighing about 3.2 Gb.

‘Cancer is a genome disease,’ explains Maria Poptsova, Head of the HSE Laboratory of Bioinformatics and one of the study’s authors, ‘When we sequence the genome in a tumour tissue, we see a spectrum of different mutations. There may be point or large-scale mutations. For example, in point mutations, one nucleotide disappears and is replaced by another. We looked at large-scale mutations where parts of the genome (from several to millions of nucleotides) were deleted, reversed, copied, and inserted in a different place. As a result of these rearrangements, genome breakpoints appear.

HSE University researchers investigated the influence of two types of DNA secondary structures – stem-loops and quadruplexes – on genome breakpoints, with the use of machine learning. The authors analysed half a million breakpoints in over 2,000 genomes of ten types of cancer. Researchers looked for genomic hotspots, considering breakpoint hotspots to be the regions with frequent and recurrent rearrangements – in other words, risk zones. It appeared that the stem-loop-based model best explains blood, brain, liver, and prostate cancer breakpoint hotspot profiles, while quadruplex-based model has higher performance for bone, breast, ovary, pancreatic, and skin cancer.

The appearance of breakpoints cannot be explained exclusively by the impact of DNA secondary structures, but their contribution is at least 20-30%. The analysis demonstrates that the impact of stem-loops and quadruplexes on breakpoint evolution depends on the type of tissue, which is determined by epigenetic factors.

‘These are the kind of markers that distinguish different kinds of tissues over the genome,’ said Maria Poptsova. ‘We are actively studying the correlation between secondary DNA structures and epigenetic marks. English researchers have already looked at the impact of DNA secondary structures and epigenetic marks on point mutations. We focused on breakpoint hotspots and are the first to determine the contribution of the two most widespread genome structures – stem-loops and quadruplexes.’

According to the study’s authors, in the future, quadruplexes may be used as therapeutic targets. If drug therapy makes them more stable, the telomerase enzyme won’t be able to work in cancer cells, and they will become vulnerable.

###

Media Contact
Liudmila Mezentseva
[email protected]

Related Journal Article

https://iq.hse.ru/en/news/293160674.html
http://dx.doi.org/10.1186/s12885-019-5653-x

Tags: BiotechnologycancerCell BiologyGeneticsMedicine/Health
Share12Tweet7Share2ShareShareShare1

Related Posts

FBXW11 Ubiquitinates YB1, Suppressing Hepatocarcinoma Growth

September 13, 2025

Advancing Liver Transplantation for Cancer with Genomics

September 13, 2025

Tumor Microenvironment Dynamics in Breast Cancer Therapy

September 13, 2025

Blocking Tumors: PD-L1 siRNA Boosts Immunotherapy

September 13, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Estimating Rice Canopy LAI Non-Destructively Across Varieties

How SARS-CoV-2 Spike Protein Activates TLR4

Boosting Xanthan Gum Production with Essential Oil By-products

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.